Live tape
Top 8, mentions 7d7,554NKE2,092 mentions▲ +0.03GOOGL1,558 mentions▲ +0.03NVDA810 mentions▲ +0.09META776 mentions▲ +0.05TSLA648 mentions▲ +0.06QQQ636 mentions▲ +0.09SPCX536 mentions▲ +0.08MSFT498 mentions▲ +0.04

Equity · Healthcare

PDEX

NASDAQ

Pro-Dex, Inc.

$64.21 −3.05% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 2, 2026
Price · Chart
33 sessions
$75 $55 7 Jul 2 Oct

The line runs $58 on 7 July through $64.21 on 2 October, on a scale from $55 to $75. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 33 sessions, 7 Jul – 2 Oct 2026
Market cap $205.7M
P/E (TTM) 15.6
52-week range $24.55 – $73.02
Avg volume 9.6K

as of Oct 2, 2026

PDEX insider trades

SEC Form 4

PDEX has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 21 November 2025.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
21 Nov 2025 Philp Katrina Marie Kramer Award 3,100 $101K
20 Nov 2025 HOVDA DAVID Award 1,000
20 Nov 2025 Philp Katrina Marie Kramer Award 1,000
20 Nov 2025 Domingo Angelita Rebamontan Award 1,000
20 Nov 2025 CABILLOT RAYMOND E Award 1,000
20 Nov 2025 Charlton Alisha Chief Financial Officer Award 1,000
20 Nov 2025 Charlton Alisha Chief Financial Officer Tax withheld 72 $2K
20 Nov 2025 Swenson Nicholas John Award 1,000
20 Nov 2025 Farrell William James III Award 1,000
20 Nov 2025 Van Kirk Richard Lee Jr Chief Executive Officer Tax withheld 72 $2K
20 Nov 2025 Domingo Angelita Rebamontan Tax withheld 72 $2K

PDEX reported financials

SEC EDGAR XBRL SEC EDGAR

PDEX reported revenue of $77.5M for the fiscal year ended 30 Jun 2026. Net income over the same period was $13.7M.

Figure Reported Period
Revenue $77.5M 30 Jun 2026 fiscal year
Net income $13.7M 30 Jun 2026 fiscal year
Diluted EPS $4.12 30 Jun 2026 fiscal year
Total assets $74.5M 30 Jun 2026 at period end
Total equity $47.6M 30 Jun 2026 at period end

PDEX earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 FY 2026 $4.12 $78M
31 Mar 2026 Q3 2026 $1.20 $20M
31 Dec 2025 Q2 2026 $0.66 $19M
30 Sep 2025 Q1 2026 $1.40 $19M
30 Jun 2025 FY 2025 $2.67 $67M
31 Mar 2025 Q3 2025 $0.98 $17M
31 Dec 2024 Q2 2025 $0.61 $17M
30 Sep 2024 Q1 2025 $0.75 $15M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

PDEX institutional holders

SEC Form 13F SEC EDGAR

2 of the 45 institutional funds we track reported a PDEX position for the quarter ended 30 Jun 2026 — a combined $582K; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Marshall Wace New position 5,156 $302K
Millennium Management New position 4,777 $280K
Citadel Advisors Exited

PDEX fails-to-deliver

SEC CNS data SEC

On 03 Sep 2026, 238 shares of PDEX failed to deliver (about $15K).

Settlement date Shares failed Notional % of shares out
03 Sep 2026 238 $15K 0.007%
28 Aug 2026 14 $908 <0.001%
24 Aug 2026 418 $27K 0.013%

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARValuation computed from SEC EDGAR filings